Advisors Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,052
| Closed | -$224K | – | 448 |
|
|
2022
Q3 | $224K | Sell |
3,052
-35
| -1% | -$2.57K | 0.01% | 430 |
|
|
2022
Q2 | $294K | Buy |
3,087
+438
| +17% | +$41.7K | 0.01% | 363 |
|
|
2022
Q1 | $312K | Sell |
2,649
-249
| -9% | -$29.3K | 0.01% | 363 |
|
|
2021
Q4 | $375K | Buy |
2,898
+177
| +7% | +$22.9K | 0.01% | 340 |
|
|
2021
Q3 | $308K | Buy |
2,721
+409
| +18% | +$46.3K | 0.01% | 351 |
|
|
2021
Q2 | $239K | Buy |
+2,312
| New | +$239K | 0.01% | 358 |
|
|
2021
Q1 | – | Sell |
-2,406
| Closed | -$219K | – | 372 |
|
|
2020
Q4 | $219K | Buy |
+2,406
| New | +$219K | 0.01% | 324 |
|
|
2020
Q1 | – | Sell |
-3,258
| Closed | -$253K | – | 293 |
|
|
2019
Q4 | $253K | Buy |
+3,258
| New | +$253K | 0.01% | 298 |
|